Antisense Oligonucleotides For The Treatment Of Leber Congenital Amaurosis


The present invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Leber congenital amaurosis.

Download PDF
Document Preview
Document History
  • Publication: Mar 14, 2013
  • Application: Apr 25, 2012
    WO NL 2012050275 W
  • Priority: Sep 6, 2011
    US US 201161531137 P
  • Priority: Sep 5, 2011
    NL NL 2007351 A

Download Citation

Sign in to the Lens